Skip to content

LIBRA PHARMA

Active Risk: not assessed Private limited companyfounded 2011active for 15 yearsVremdesesteenweg 259, 2531 BoechoutKBO/BCE: BE 0833.903.555 #10 company by total assets in Boechout, Finance and insurance sector

Lifetime

14 annual accounts with figures on one time axis
peak of €298,457 in 2012
€178,051▲ 150%
peak of €146,117 in 2012
€137,007▲ 215%
peak of €1.2m in 2025
€1.2m▲ 13.0%
€2.4m▲ 302%
Board2 names since 2011
2 directors and 1 other
Documentsfilings and deeds
07-07-202624 days before the deadline
2025abbreviated format
Gross margin from €71,160 to €178,051Result from €43,462 to €137,007Equity from €1.1m to €1.2mDebts from €591,834 to €2.4mInvestments €2.0mCash from €24,350 to €4,502

Key points

from the 2025 annual accounts

Equity

€1.2m ▲ 13.0%

LIBRA PHARMA has made a profit in every financial year since 2012.

Result

€137,007 ▲ 215%
€43,5002024€137,0002025

The result rose in 2025 from €43,462 to €137,007.

Turnover

≈ €280,000 estimated

The abbreviated format states no turnover.

Debts

€2.4m ▲ 302%
Financial debts
+1.6
Taxes and wages
+0.07
Suppliers
+0.01
The rest
+0.06

Debts rose by €1.8m in 2025.

Investments

€91,771 6.7 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Five of the last ten came late. The 2021 accounts came in latest, 60 days after the end of the period.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 23-08-2023
Director, since 01-07-2024

Shares in 2 companies, and

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0833903555
appointed as director General meeting of 01-07-2024 · Gazette deed
reappointed as director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 18-08-2023 · Gazette deed
Registered office moved within Vremde The registered office moved from Weverstraat 41, 2531 Vremde to Vremdesesteenweg 259, 2531 Vremde · Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
LIBRA PHARMA Boechout €3.6m €178,051 33.3% -
JAX-Beheer Grobbendonk €3.4m €161,714 5.3% -
Otter Holding Bornem €4.4m €163,944 22.3% -
POEKA Mol €2.7m €171,623 76.8% -
DEMVAN De Panne €3.7m €168,573 87.5% -
Five Aces Hamme (Vl.) €3.6m €171,705 60.4% -
BNF Wellen €3.5m €159,705 12.6% -

These companies have the same main activity as LIBRA PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €2.7m and €4.4m, founded between 2010 and 2012.

Official details

Source: KBO
Status
Active since 16-02-2011Normal situation
Activity
Activities of holding companiesNACE 64210and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.196.649.5282531 Boechout, since 16-02-2011
Financial year end
31 December
Peppol
Reachable since 18-09-2026
Company details

Annual accounts 2025

€3.6m▲ 117%
Employeeson 31-12-2025
2
Filing
Filed on 07-07-2026, 24 days before the end of the filing period
Financials

Insights on LIBRA PHARMA

LIBRA PHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €298,457 in 2012 to €178,051 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LIBRA PHARMA

What is the company number of LIBRA PHARMA?
The company number of LIBRA PHARMA is 0833.903.555. The VAT number is the same number with BE in front: BE 0833.903.555.
Where is LIBRA PHARMA based?
The registered office is at Vremdesesteenweg 259, 2531 Boechout.Company details
What does LIBRA PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of LIBRA PHARMA?
LIBRA PHARMA is a private limited company (BV).
When was LIBRA PHARMA founded?
LIBRA PHARMA was founded on 16-02-2011.
Is LIBRA PHARMA still active?
Yes, LIBRA PHARMA is an active enterprise in the KBO register.
How many employees does LIBRA PHARMA have?
LIBRA PHARMA had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does LIBRA PHARMA fall under?
In its 2025 annual accounts, LIBRA PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of LIBRA PHARMA?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €178,051 and 33 comparable companies (NACE 64210). It probably lies between €240,000 and €350,000.
Is LIBRA PHARMA profitable?
In financial year 2025, LIBRA PHARMA made a profit of €137,007.
Where can I find the annual accounts of LIBRA PHARMA?
LIBRA PHARMA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LIBRA PHARMA due?
LIBRA PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.